High levels of LINE-1 transposable elements expressed in Kaposi's sarcoma-associated herpesvirus-related primary effusion lymphoma

被引:2
|
作者
Ahuja, Anuj [1 ]
Journo, Guy [1 ]
Eitan, Ron [1 ]
Rubin, Eitan [2 ]
Shamay, Meir [1 ]
机构
[1] Bar Ilan Univ, Azrieli Fac Med, Daniella Lee Casper Lab Viral Oncol, Safed, Israel
[2] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol & Immunol, Fac Hlth Sci, IL-84105 Beer Sheva, Israel
基金
以色列科学基金会;
关键词
IMMUNODEFICIENCY-VIRUS-INFECTION; ENDOGENOUS RETROVIRUS HERV-K18; ENCODED REVERSE-TRANSCRIPTASE; GENE-EXPRESSION; CELL-PROLIFERATION; DNA; RETROTRANSPOSITION; DIFFERENTIATION; HYPOMETHYLATION; IDENTIFICATION;
D O I
10.1038/s41388-020-01549-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Kaposi's sarcoma-associated herpesvirus (KSHV, HHV-8) is a gamma herpesvirus associated with several human malignancies. Transposable elements (TEs) are ubiquitous in eukaryotic genomes, occupying about 45% of the human genome. TEs have been linked with a variety of disorders and malignancies, though the precise nature of their contribution to many of them has yet to be elucidated. Global transcriptome analysis for differentially expressed TEs in KSHV-associated primary effusion lymphoma (PEL) cells (BCBL1 and BC3) revealed large number of differentially expressed TEs. These differentially expressed TEs include LTR transposons, long interspersed nuclear elements (LINEs), and short interspersed nuclear elements (SINEs). Further analysis of LINE-1 (L1) elements revealed expression upregulation, hypo-methylation, and transition into open chromatin in PEL. In agreement with high L1 expression, PEL cells express ORF1 protein and possess high reverse transcriptase (RT)-activity. Interestingly, inhibition of this RT-activity suppressed PEL cell growth. Collectively, we identified high expression of TEs, and specifically of L1 as a critical component in the proliferation of PEL cells. This observation is relevant for the treatment of KSHV-associated malignancies since they often develop in AIDS patients that are treated with RT inhibitors with potent inhibition for both HIV and L1 RT activity.
引用
收藏
页码:536 / 550
页数:15
相关论文
共 50 条
  • [21] Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications
    Gruffaz, Marion
    Zhou, Shenghua
    Vasan, Karthik
    Rushing, Teresa
    Michael, Qing Liu
    Lu, Chu
    Jung, Jae U.
    Gao, Shou-Jiang
    MBIO, 2018, 9 (03):
  • [22] High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease
    Oksenhendler, E
    Boulanger, E
    Galicier, L
    Du, MQ
    Dupin, N
    Diss, TC
    Hamoudi, R
    Daniel, MT
    Agbalika, F
    Boshoff, C
    Clauvel, JP
    Isaacson, PG
    Meignin, V
    BLOOD, 2002, 99 (07) : 2331 - 2336
  • [23] Distinct Profiles of Antibodies to Kaposi Sarcoma-Associated Herpesvirus Antigens in Patients with Kaposi Sarcoma, Multicentric Castleman Disease, and Primary Effusion Lymphoma
    Burbelo, Peter D.
    Issa, Alexandra T.
    Ching, Kathryn H.
    Wyvill, Kathleen M.
    Little, Richard F.
    Iadarola, Michael J.
    Kovacs, Joseph A.
    Yarchoan, Robert
    JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (12): : 1919 - 1922
  • [24] Kaposi's sarcoma-associated herpesvirus transmission and primary infection
    Bagni, Rachel
    Whitby, Denise
    CURRENT OPINION IN HIV AND AIDS, 2009, 4 (01) : 22 - 26
  • [25] Establishing and characterizing a new primary effusion lymphoma cell line harboring Kaposi’s sarcoma–associated herpesvirus
    Madori Osawa
    Sohtaro Mine
    Shinichiro Ota
    Kengo Kato
    Tsuyoshi Sekizuka
    Makoto Kuroda
    Michiyo Kataoka
    Hitomi Fukumoto
    Yuko Sato
    Takayuki Kanno
    Hideki Hasegawa
    Keiji Ueda
    Masashi Fukayama
    Takuya Maeda
    Soichiro Kanoh
    Akihiko Kawana
    Yuji Fujikura
    Harutaka Katano
    Infectious Agents and Cancer, 11
  • [26] A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus
    Dittmer, D
    Lagunoff, M
    Renne, R
    Staskus, K
    Haase, A
    Ganem, D
    JOURNAL OF VIROLOGY, 1998, 72 (10) : 8309 - 8315
  • [27] Kaposi sarcoma-associated herpesvirus/human herpesvirus 8-associated extracavitary primary effusion lymphoma presenting as multiple lymphomatous polyposis
    Oster, Cyrus
    Stein, Theodore
    Kitahara, Sumire
    Alkan, Serhan
    Huang, Qin
    HUMAN PATHOLOGY, 2018, 79 : 177 - 183
  • [28] Widespread Traces of Lytic Kaposi Sarcoma-Associated Herpesvirus in Primary Effusion Lymphoma at Single-Cell Resolution
    Rondeau, Nicole C.
    Finlayson, Michael O.
    Miranda, Jj L.
    MICROBIOLOGY RESOURCE ANNOUNCEMENTS, 2020, 9 (45):
  • [29] Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases - Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease
    Parravicini, C
    Chandran, B
    Corbellino, M
    Berti, E
    Paulli, M
    Moore, PS
    Chang, Y
    AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (03): : 743 - 749
  • [30] Fumagillin, a potent angiogenesis inhibitor, induces Kaposi sarcoma-associated herpesvirus replication in primary effusion lymphoma cells
    Kanno, Takayuki
    Uehara, Taeko
    Osawa, Madori
    Fukumoto, Hitomi
    Mine, Sohtaro
    Ueda, Keiji
    Hasegawa, Hideki
    Katano, Harutaka
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 463 (04) : 1267 - 1272